Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04505956 · ClinicalTrials.gov registry record · NA
A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 171
- Enrollment target
NCT04505956 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 171 participants.
The verdict
NCT04505956, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 171 participants
- Enrollment target
Study Summary
Flexible ureteroscopy is characterized as first-line therapy for the treatment of renal stones \< 2 cm in size. This involves passing a flexible endoscope into the renal pelvis through the urethra, bladder and ureter in a retrograde fashion. Holmium: YAG laser remains the preferred energy modality to subsequently break stones of this size into fragments small enough to remove or pass spontaneously through the ureter. Advances in the understanding of laser energy delivery have led to the recent commercialization of the "Moses Effect" - the creation of vapor bubbles/cavities between the laser fiber tip and the target through which laser energy can more efficiently travel. Lumenis was the first to optimize this laser phenomenon and market it as "Moses Technology" in their Lumenis Pulse P120H laser system. This system is already FDA approved through the 510K pathway and is commercially available. The purpose of this study is to evaluate the potential of Moses laser technology to reduce operative time compared to non-Moses settings for ureteroscopic treatment of nephrolithiasis.
Interventions
- DEVICE Holmium laser lithotripsy with Moses Technology
- DEVICE Holmium laser lithotripsy without Moses Technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2021-01-13 |
| Est. Completion | 2023-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04505956
The ClinicalTrials.gov registry entry for NCT04505956 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Holmium laser lithotripsy with Moses Technology is the first listed.
NCT04505956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04505956 about?
NCT04505956 is a clinical study titled "A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology". Flexible ureteroscopy is characterized as first-line therapy for the treatment of renal stones \< 2 cm in size. This involves passing a flexible endoscope into the renal pelvis through the urethra, bladder and ureter in a retrograde fashion. Holmium: YAG laser remains the preferred energy modality t...
What is the current status of trial NCT04505956?
This trial is currently completed. It is a NA study. The enrollment target is 171 participants. The study started on 2021-01-13. Estimated completion is 2023-12-01.
What interventions are being tested in trial NCT04505956?
The interventions under investigation include: Holmium laser lithotripsy with Moses Technology (DEVICE), Holmium laser lithotripsy without Moses Technology (DEVICE).
Who is sponsoring clinical trial NCT04505956?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.